AtriCure Inc
ATRC36.350USD
+1.940+5.64%
종가 08/04, 16:00（ET）시세는 15분 지연됩니다
1.81B시가총액
손실P/E TTM
자세한 내용은 AtriCure Inc 회사
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
회사 정보
종목 코드 ATRC
회사 이름AtriCure Inc
상장일Aug 05, 2005
CEOMr. Michael H. (Mike) Carrel, CPA
직원 수1300
유형Ordinary Share
회계 연도 종료Aug 05
주소7555 Innovation Way
도시MASON
증권 거래소NASDAQ Global Market Consolidated
국가United States of America
우편 번호45040
전화15137554100
웹사이트https://www.atricure.com
종목 코드 ATRC
상장일Aug 05, 2005
CEOMr. Michael H. (Mike) Carrel, CPA
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
718.94K
+0.11%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
125.59K
+0.66%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
92.17K
+20.06%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
86.96K
+23.01%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
74.37K
+1.12%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
68.55K
+1.21%
Ms. Regina E. (Reggie) Groves
Ms. Regina E. (Reggie) Groves
Independent Director
Independent Director
36.17K
+17.56%
Mr. Sven A. Wehrwein, CPA
Mr. Sven A. Wehrwein, CPA
Independent Director
Independent Director
34.37K
+18.64%
Ms. Deborah H. (Deb) Telman
Ms. Deborah H. (Deb) Telman
Independent Director
Independent Director
22.18K
+32.18%
Mr. Shlomo Nachman
Mr. Shlomo Nachman
Independent Director
Independent Director
18.51K
+41.20%
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
718.94K
+0.11%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
125.59K
+0.66%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
92.17K
+20.06%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
86.96K
+23.01%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
74.37K
+1.12%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
68.55K
+1.21%
수익 분석
통화: USD마지막 업데이트: Sun, Jul 6
통화: USD마지막 업데이트: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
Appendage Management-United states
42.09M
34.05%
Open Ablation - United states
33.31M
26.94%
Pain management
17.27M
13.97%
Appendage management -International
9.67M
7.83%
Open ablation -International
8.99M
7.28%
Other
12.28M
9.94%
지역별USD
이름
수익
비율
United States
101.15M
81.82%
Europe
14.20M
11.49%
Asia
6.78M
5.49%
Other international
1.49M
1.20%
사업별
지역별
사업별USD
이름
수익
비율
Appendage Management-United states
42.09M
34.05%
Open Ablation - United states
33.31M
26.94%
Pain management
17.27M
13.97%
Appendage management -International
9.67M
7.83%
Open ablation -International
8.99M
7.28%
Other
12.28M
9.94%
주식 보유 통계
마지막 업데이트: Tue, May 20
마지막 업데이트: Tue, May 20
주주
주주 유형
주주
주주
비율
The Vanguard Group, Inc.
9.46%
AllianceBernstein L.P.
7.40%
BlackRock Institutional Trust Company, N.A.
7.19%
Hood River Capital Management LLC
6.03%
Macquarie Investment Management
4.90%
Other
65.02%
주주
주주
비율
The Vanguard Group, Inc.
9.46%
AllianceBernstein L.P.
7.40%
BlackRock Institutional Trust Company, N.A.
7.19%
Hood River Capital Management LLC
6.03%
Macquarie Investment Management
4.90%
Other
65.02%
주주 유형
주주
비율
Investment Advisor
56.65%
Investment Advisor/Hedge Fund
33.71%
Hedge Fund
10.66%
Individual Investor
3.55%
Research Firm
1.93%
Pension Fund
0.75%
Bank and Trust
0.50%
Sovereign Wealth Fund
0.23%
Family Office
0.07%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
531
53.52M
108.11%
-4.10M
2025Q1
544
53.44M
107.95%
-4.07M
2024Q4
526
50.00M
102.31%
-11.07M
2024Q3
522
53.78M
110.47%
-8.64M
2024Q2
511
54.11M
111.85%
-4.03M
2024Q1
517
53.02M
109.65%
-1.47M
2023Q4
515
50.20M
105.93%
-1.70M
2023Q3
504
48.87M
103.22%
-3.82M
2023Q2
499
48.88M
103.48%
-3.46M
2023Q1
503
48.62M
102.63%
-1.48M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
The Vanguard Group, Inc.
4.70M
9.5%
+61.17K
+1.32%
Mar 31, 2025
AllianceBernstein L.P.
3.68M
7.43%
-158.60K
-4.14%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
3.57M
7.21%
-92.41K
-2.52%
Mar 31, 2025
Hood River Capital Management LLC
3.00M
6.06%
+75.48K
+2.58%
Mar 31, 2025
Macquarie Investment Management
2.44M
4.92%
+61.60K
+2.59%
Mar 31, 2025
Champlain Investment Partners, LLC
2.14M
4.32%
-390.65K
-15.45%
Mar 31, 2025
Two Sigma Investments, LP
1.33M
2.68%
+75.83K
+6.06%
Mar 31, 2025
First Light Asset Management, LLC
1.31M
2.66%
-654.50K
-33.24%
Mar 31, 2025
State Street Global Advisors (US)
1.28M
2.58%
-68.53K
-5.09%
Mar 31, 2025
UBS Asset Management (Switzerland)
1.26M
2.54%
+537.08K
+74.31%
Mar 31, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Aug 2
마지막 업데이트: Sat, Aug 2
이름
비율
SPDR S&P Health Care Equipment ETF
1.81%
Harbor Human Capital Factor US Small Cap ETF
0.76%
NYLI Healthy Hearts ETF
0.47%
First Trust Small Cap Growth AlphaDEX Fund
0.45%
Invesco NASDAQ Future Gen 200 ETF
0.43%
Amplify Etho Climate Leadership U.S. ETF
0.3%
JPMorgan Fundamental Data Science Small Core ETF
0.26%
Franklin US Small Cap Multifactor Index ETF
0.25%
First Trust Small Cap Core Alphadex Fund
0.24%
iShares U.S. Medical Devices ETF
0.18%
더 보기
SPDR S&P Health Care Equipment ETF
비율1.81%
Harbor Human Capital Factor US Small Cap ETF
비율0.76%
NYLI Healthy Hearts ETF
비율0.47%
First Trust Small Cap Growth AlphaDEX Fund
비율0.45%
Invesco NASDAQ Future Gen 200 ETF
비율0.43%
Amplify Etho Climate Leadership U.S. ETF
비율0.3%
JPMorgan Fundamental Data Science Small Core ETF
비율0.26%
Franklin US Small Cap Multifactor Index ETF
비율0.25%
First Trust Small Cap Core Alphadex Fund
비율0.24%
iShares U.S. Medical Devices ETF
비율0.18%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
